Sort
40,608 grants matching “prostate cancer”
CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER
$1,235,070Sidney Kimmel Cancer Center · U01 · FY2002 · CA
PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)
$1,234,475Thomas Riley · Information Management Services, Inc. · N02 · FY2025 · CA
Molecular Cytogenetics of Solid Tumors
$1,234,398Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
NEW AWARD - DEFINING OVEREXPRESSION OF MYBL2 AS A DRIVER OF LETHAL PROSTATE CANCER...SIGNED 4/13/2020, EFFECTIVE 5/1/2020, DISTRIBUTED 4/14/2020, FAADC 4/15/2020
$1,234,189The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2020 · Defense Health Agency
NEUROPILIN-2: NOVEL BIOMARKER AND THERAPEUTIC TARGET FOR AGGRESSIVE PROSTATE CANCER
$1,233,750University Of Massachusetts Medical School · · FY2012 · Department of Defense
SPORE In Prostate Cancer
$1,233,307William George Nelson · Johns Hopkins University · P50 · FY2013 · CA
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk
$1,233,023Deirdre Kay Tobias · Brigham And Women'S Hospital · U01 · FY2024 · CA
Surveillance Epidemiology and End Results (SEER) Program - Hawaii
$1,232,092Marc T Goodman · University Of Hawaii At Manoa · N01 · FY2009 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
$1,232,006Kenneth J. Pienta · Johns Hopkins University · U01 · FY2019 · CA
The Center for Systemic Control of Cyto-Networks
$1,230,000Chih-Ming Ho · University Of California Los Angeles · PN2 · FY2010 · EY
COTARGETING THE TRINITY OF DNA DAMAGE REPAIR SENSING KINASES IN PROSTATE CANCER.
$1,230,000The University Of Texas Southwestern Medical Center · · FY2021 · Department of the Army
DISSECTION OF MOLECULAR ASSOCIATIONS OF RESPONSE TO NEOADJUVANT ANTIANDROGEN THERAPIES IN HIGH-RISK LOCALIZED PROSTATE CANCER
$1,229,700Dana-Farber Cancer Institute, Inc. · · FY2024 · Defense Health Agency
Pharmacogenetic Studies
$1,229,296Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
VALIDATING CD46 AS A PROMISING BIOMARKER IN ADVANCED PROSTATE CANCER
$1,229,296Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
TRNA-MEDIATED REGULATION OF PROSTATE CANCER BIOLOGY
$1,229,184University Of Chicago · · FY2022 · Defense Health Agency
DNA Sequencing
$1,228,953Trevor K Archer · National Institute Of Environmental Health Sciences · ZIC · FY2015 · ES
PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY.
$1,228,125The Johns Hopkins University · · FY2021 · Department of the Army
POSITIVE SUBSET OF PROSTATE CANCER OVERREPRESENTED IN AFRICAN-AMERICAN MEN: SYSTEMIC TREATMENT IMPLICATIONS.
$1,228,125The Johns Hopkins University · · FY2021 · Defense Health Agency
GENETIC AND GENOMIC DETERMINANTS OF HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY AS TREATMENT SELECTION MARKERS FOR LETHAL PROSTATE CANCER...NEW AWARD
$1,228,125The Johns Hopkins University · · FY2019 · Defense Health Agency
CONCURRENT ADMINISTRATION OF BIPOLAR ANDROGEN THERAPY AND NIVOLUMAB IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (COMBAT-CRPC)...NEW AWARD
$1,228,124The Johns Hopkins University · · FY2019 · Defense Health Agency
METABOLOMIC AND METHYLATION PATHWAYS ASSOCIATED WITH BLACK-WHITE DISPARITY IN LETHAL PROSTATE CANCER.
$1,227,973The Johns Hopkins University · · FY2021 · Defense Health Agency
The connection of innate and adaptive anti-cancer immunity
$1,227,316John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
INVESTIGATING THE CANONICAL POLYCOMB REPRESSIVE COMPLEX 1 (CPRC1) AS AN INTRINSIC MECHANISM OF RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER
$1,226,730Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
Mouse Model of Cell Cycle Deregulation in Cancer
$1,226,008University Of Texas Md Anderson Can Ctr · U01 · FY2004 · ES
NEW AWARD - DECIPHERING DDX3-MITOCHONDRIAL AXIS IN PROSTATE CANCER ETHNIC DISPARITY, SIGNED 4/16/2020, EFFECTIVE 5/1/2020, DISTRIBUTED 4/20/2020, FAADC 4/20/2020
$1,225,804The Johns Hopkins University · · FY2020 · Defense Health Agency